Calcium preconditioning, but not ischemic preconditioning, bypasses the adenosine triphosphate-dependent potassium (K(ATP)) channel

Journal of Surgical Research

Volumn 85, Issue 1, 1999, Pages 77-82

  Meldrum, Daniel R ^a   Cain, Brian S ^a   Meng, Xianzhong ^a   Cleveland Jr , Joseph C ^a   Shames, Brian D ^a   Donnahoo, Kirstan K ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION PREVENTION; HEART MUSCLE COMPLIANCE; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0032775891     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5671     Document Type: Article

References (48)

1. Meldrum D. R. Tumor necrosis factor in the heart (review). Am. J. Physiol. 274:1998;R577.
2. Meldrum D. R., Dinarello C. A., Meng X., Cleveland J. C., Cain B. S., Shames B. D., Banerjee A., Harken A. H. Ischemic preconditioning decreases post-ischemic myocardial TNF: Potential ultimate effector mechanism of preconditioning. Circulation. 98:1998.
3. Cleveland J. C., Meldrum D. R., Cain B. S., Banerjee A., Harken A. H. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Circulation. 96:1997;29.
4. 1-adrenoceptors. Am. J. Physiol. 273:1997;H902.
5. Cleveland J. C., Meldrum D. R., Rowland R. T., Banerjee A., Harken A. H. Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive potassium channel. J. Mol. Cell. Cardiol. 29:1997;175.
6. Brown J. M., Grosso M. A., Terada L. S., Whitman G. J., Banerjee A., White C. W., Harken A. H., Repine J. E. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc. Natl. Acad. Sci. USA. 86:1989;2516.
7. Cain B. S., Meldrum D. R., Harken A. H., McIntyre R. C. Physiologic basis for anti-cytokine clinical trials. J. Am. Coll. Surg. 186:1997;337.
8. Meldrum D. R., Cain B. S., Cleveland J. C., Meng X., Ayala A., Banerjee A., Harken A. H. Adenosine decreases post-ischemic myocardial TNFa production: Anti-inflammatory implications for preconditioning and transplantation. Immunology. 92:1997;472.
9. Meldrum D. R., Cleveland J. C., Moore E. E., Partrick D. A., Banerjee A., Harken A. H. Adaptive and maladaptive mechanisms of cellular priming. Ann. Surg. 226:1997;587.
10. 1-adrenoceptor mediated, protein synthesis independent mechanism. Am. J. Physiol. 272:1997;R718.
11. Meldrum D. R., Cleveland J. C., Rowland R. T., Banerjee A., Harken A. H., Meng X. Early and delayed preconditioning: Differential mechanisms and additive protection. Am. J. Physiol. 273:1997;H725.
12. Meldrum D. R. Mechanisms of cardiac preconditioning: Ten years after the discovery of ischemic preconditioning. J. Surg. Res. 73:1997;1.
13. Itoh G., Jie T., Tamura J., Suzuki M., Suzuki Y., Ikeda M., Koike M., Nomura M. Apoptosis and human myocardial ischemic damage, including conduction system. Basic Appl. Myol. 6:1996;237.
14. Ayala A., Herndon C. D., Lehman D. L., Ayala C. A., Chaudry I. H. Differential induction of apoptosis in lymphoid tissues during sepsis: Variation in onset, frequency, and the nature of the mediators. Blood. 87:1996;4261.
15. Krown K. A., Page M. T., Nguyen C., Zechner D., Gutierrez V., Comstock K. L., Glembotski C. G., Quintana P. J. E., Sabbadini R. A. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98:1996;2854.
16. Piot C. P., Padmanaban D., Ursell P. C., Sievers R. E., Wolfe C. L. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation. 96:1997;1598.
17. Meldrum D. R., Cleveland J. C., Sheridan B. C., Rowland R. T., Banerjee A., Harken A. H. Cardiac preconditioning with calcium: Clinically accessible myocardial protection. J. Thorac. Cardiovasc. Surg. 112:1996;778.
18. 2+ induced cardioadaptation to ischemia-reperfusion injury. Am. J. Physiol. 271:1996;R1718.
19. Gross G. J., Auchampach J. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70:1992;223.
20. Grover G. J., Sleph P. G., Dzwoncyzk S. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc. Drugs Ther. 4:1990;465.
21. ATP blockade in type II diabetes and preconditioning in cardiovascular diseases. Circulation. 94:1996;2297.
22. Ashraf M., Suleiman J., Ahmad M. Calcium preconditioning elicits a unique protection against the calcium paradox injury in rat heart: Role of adenosine. Circ. Res. 74:1994;360.
23. Meldrum D. R., Cleveland J. C., Sheridan B. C., Rowland R. T., Banerjee A., Harken A. H. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann. Thorac. Surg. 61:1996;1273.
24. Brown J. M., White C. W., Terada L. S., Grosso M. A., Shanley P. F., Mulvin D. W., Banerjee A., Whitman G. J., Harken A. H., Repine J. E. Interleukin-1 pretreatment decreases ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA. 87:1990;5026.
25. Banerjee A., Locke-Winter C., Rogers K. B., Mitchell M. B., Bensard D. D., Brew E. C., Cairns C. B., Harken A. H. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1 adrenergic mechanism. Circ. Res. 73:1993;656.
26. Meldrum D. R., Cleveland J. C., Sheridan B. C., Rowland R. T., Banerjee A., Harken A. H. Differential effects of adenosine preconditioning on the post-ischemic rat myocardium. J. Surg. Res. 65:1996;156.
27. Meldrum D. R., Dinarello C. A., Cleveland J. C., Shapiro L., Sheridan B. C., Harken A. H. p38 MAP kinase mediates myocardial ischemia reperfusion injury. Surg. Forum. XLVII:1997;335.
28. Meldrum D. R., Mitchell M. B., Banerjee A., Harken A. H. Cardiac preconditioning: Induction of endogenous tolerance to ischemia-reperfusion injury. Arch. Surg. 128:1993;1208.
29. Meldrum D. R., Dinarello C. A., Cleveland J. C., Cain B. S., Shames B. D., Meng X., Harken A. H. Hydrogen peroxide induces tumor necrosis factor-alpha mediated cardiac injury by a P38 mitogen activated protein kinase dependent mechanism. Surgery. 124:1998;291.
30. Meldrum D. R., Cleveland J. C., Cain B. S., Meng X., Harken A. H. Increased myocardial TNF-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann. Thorac. Surg. 65:1998;439.
31. Meldrum D. R., Shenkar R., Sheridan B. C., Cain B. S., Abraham E., Harken A. H. Hemorrhage activates myocardial NFkB and increases tumor necrosis factor in the heart. J. Mol. Cell. Cardiol. 29:1997;2849.
32. Murry C., Jennings R., Reimer K. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124.
33. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607.
34. Cleveland J. C., Meldrum D. R., Rowland R. T., Sheridan B. C., Banerjee A., Harken A. H. The obligate role of protein kinase C in mediating clinically accessible cardiac preconditioning. Surgery. 120:1996;345.
35. Meldrum D. R., Cleveland J. C., Rowland R. T., Banerjee A., Harken A. H. Calcium induced inotropy is in part mediated by protein kinase C. J. Surg. Res. 63:1996;400.
36. Meldrum D. R., Cleveland J. C., Mitchell M. B., Rowland R. T., Banerjee A., Harken A. H. Constructive priming of myocardium against ischemia-reperfusion injury. Shock. 6:1996;238.
37. Meldrum D. R., Cleveland J. C., Sheridan B. C., Meng X., Robertson F., Cain B. S., Harken A. H., Banerjee A. Protein kinase C isoform diversity in preconditioning. J. Surg. Res. 69:1997;183.
38. Mitchell M. B., Meng X., Parker C. G., Harken A. H., Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76:1995;73.
39. Thornton J., Striplin S., Liu G. S., Swafford A., Stanley A. W. H., Van Winkle D. M., Downey J. M. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am. J. Physiol. 259:1990;H1822.
40. 1 selective adenosine analogues protects the heart against infarction. Circulation. 85:1992;659.
41. Goto M., Liu Y., Yang X. M., Ardell J. L., Cohen M. V., Downey J. M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 77:1995;611.
42. Brew E. B., Mitchell M. B., Rehring T. F., Gamboni-Robertson F., Mcintyre R. C., Harken A. H., Banerjee A. The role of bradykinin in cardiac functional protection after global ischemia-reperfusion in the rat heart. Am. J. Physiol. 269:1995;H1370.
43. Cain B. S., Meldrum D. R., Meng X., Shames B. D., Banerjee A., Harken A. H. Calcium preconditioning in human myocardium. Ann. Thorac. Surg. 65:1998;1065.
44. + channel. Circ. Res. 77:1995;1030.
45. + channel blocker. Circulation. 90:1994;700.
46. Klimt C. R., Knautterud G. L., Meinert C. L., Prout T. E. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes. 19:1970;747.
47. Rytter L., Troelsen S., Beck-Nielsen H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care. 8:1985;230.
48. Kloner R. A., Shook T. Previous angina alters in-hospital outcome in TIMI-4: A clinical correlate to preconditioning. Circulation. 91:1995;37.